Daiken Medical Co., Ltd. (TYO:7775)
501.00
+1.00 (0.20%)
Mar 12, 2025, 3:30 PM JST
Daiken Medical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 2,974 | 2,739 | 2,516 | 2,518 | 2,170 | 2,365 | Upgrade
|
Cash & Short-Term Investments | 2,974 | 2,739 | 2,516 | 2,518 | 2,170 | 2,365 | Upgrade
|
Cash Growth | 18.20% | 8.86% | -0.08% | 16.04% | -8.25% | 6.68% | Upgrade
|
Receivables | 2,778 | 2,479 | 2,530 | 2,431 | 2,587 | 2,726 | Upgrade
|
Inventory | 1,268 | 1,438 | 1,514 | 1,544 | 1,421 | 1,173 | Upgrade
|
Prepaid Expenses | - | 24 | 18 | 19 | 23 | 18 | Upgrade
|
Other Current Assets | 147.84 | 50 | 60 | 60 | 71 | 122 | Upgrade
|
Total Current Assets | 7,168 | 6,730 | 6,638 | 6,572 | 6,272 | 6,404 | Upgrade
|
Property, Plant & Equipment | 3,942 | 3,986 | 4,070 | 4,119 | 4,225 | 4,300 | Upgrade
|
Long-Term Investments | - | 70 | 65 | 53 | 67 | 69 | Upgrade
|
Other Intangible Assets | 12.21 | 13 | 9 | 15 | 21 | 29 | Upgrade
|
Long-Term Deferred Tax Assets | 205.59 | 205 | 230 | 160 | 166 | 194 | Upgrade
|
Other Long-Term Assets | 68.56 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
Total Assets | 11,396 | 11,006 | 11,013 | 10,920 | 10,752 | 10,997 | Upgrade
|
Accounts Payable | 467.28 | 1,066 | 1,117 | 1,004 | 957 | 967 | Upgrade
|
Accrued Expenses | 84.54 | 65 | 70 | 70 | 179 | 445 | Upgrade
|
Short-Term Debt | 920 | 1,114 | 1,058 | 1,019 | 1,033 | 895 | Upgrade
|
Current Portion of Long-Term Debt | 489.97 | 389 | 659 | 597 | 704 | 898 | Upgrade
|
Current Portion of Leases | - | 8 | 9 | 11 | 11 | 8 | Upgrade
|
Current Income Taxes Payable | 160.58 | 671 | 428 | 427 | 259 | 505 | Upgrade
|
Other Current Liabilities | 949.31 | 26 | 28 | 23 | 204 | 64 | Upgrade
|
Total Current Liabilities | 3,072 | 3,339 | 3,369 | 3,151 | 3,347 | 3,782 | Upgrade
|
Long-Term Debt | 930.94 | 623 | 1,013 | 1,280 | 1,177 | 1,091 | Upgrade
|
Long-Term Leases | - | 8 | 16 | 26 | 28 | 24 | Upgrade
|
Other Long-Term Liabilities | 17.14 | 14 | 19 | 18 | 18 | 19 | Upgrade
|
Total Liabilities | 4,020 | 3,984 | 4,417 | 4,475 | 4,570 | 4,916 | Upgrade
|
Common Stock | 495.88 | 495 | 495 | 495 | 495 | 495 | Upgrade
|
Additional Paid-In Capital | 400.88 | 400 | 400 | 400 | 400 | 400 | Upgrade
|
Retained Earnings | 8,274 | 7,920 | 7,506 | 7,368 | 7,112 | 7,011 | Upgrade
|
Treasury Stock | -1,827 | -1,826 | -1,826 | -1,826 | -1,826 | -1,826 | Upgrade
|
Comprehensive Income & Other | 31.78 | 33 | 21 | 8 | 1 | 1 | Upgrade
|
Shareholders' Equity | 7,376 | 7,022 | 6,596 | 6,445 | 6,182 | 6,081 | Upgrade
|
Total Liabilities & Equity | 11,396 | 11,006 | 11,013 | 10,920 | 10,752 | 10,997 | Upgrade
|
Total Debt | 2,341 | 2,142 | 2,755 | 2,933 | 2,953 | 2,916 | Upgrade
|
Net Cash (Debt) | 633.01 | 597 | -239 | -415 | -783 | -551 | Upgrade
|
Net Cash Per Share | 22.03 | 20.78 | -8.32 | -14.45 | -27.26 | -19.18 | Upgrade
|
Filing Date Shares Outstanding | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | Upgrade
|
Total Common Shares Outstanding | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | Upgrade
|
Working Capital | 4,096 | 3,391 | 3,269 | 3,421 | 2,925 | 2,622 | Upgrade
|
Book Value Per Share | 256.75 | 244.43 | 229.60 | 224.34 | 215.19 | 211.67 | Upgrade
|
Tangible Book Value | 7,364 | 7,009 | 6,587 | 6,430 | 6,161 | 6,052 | Upgrade
|
Tangible Book Value Per Share | 256.33 | 243.97 | 229.29 | 223.82 | 214.46 | 210.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.